Open AccessRefining evidence-based retinopathy of prematurity screening guidelines: The SCREENROP study
Author(s) -
Kourosh Sabri,
Sandesh Shivananda,
Forough Farrokhyar,
Alessandro Selvitella,
Bethany Easterbrook B Kin,
Wendy Seidlitz,
Shoo K. Lee
Publication year - 2019
Publication title -
paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.55
H-Index - 43
eISSN - 1918-1485
pISSN - 1205-7088
DOI - 10.1093/pch/pxz085
Subject(s) - retinopathy of prematurity , medicine , gestational age , pediatrics , birth weight , logistic regression , cohort , retrospective cohort study , blinding , cohort study , intensive care , neonatal intensive care unit , pregnancy , intensive care medicine , clinical trial , genetics , biology
Retinopathy of prematurity (ROP) is a potentially blinding condition affecting premature infants for which less than 10% of babies undergoing screening require treatment. This study assessed and validated predictors of developing clinically significant ROP (type 2 or worse) and ROP requiring treatment.